WT1 and neoplasm: In diffuse midline glioma K27-altered tumors, WT1 appears to have tumor suppressor activity as transient overexpression of WT1 or Cas9 targeted removal of the repressive H3K27me3 mark on the WT1 promoter resulted in slowed growth of H3.3 K27M patient-derived cells [140].